Eintrag weiter verarbeiten
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women
Gespeichert in:
| Zeitschriftentitel: | Women's Health |
|---|---|
| Personen und Körperschaften: | |
| In: | Women's Health, 3, 2007, 4, S. 409-415 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Huber, Johannes C Huber, Johannes C |
|---|---|
| author |
Huber, Johannes C |
| spellingShingle |
Huber, Johannes C Women's Health Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women General Medicine |
| author_sort |
huber, johannes c |
| spelling |
Huber, Johannes C 1745-5065 1745-5065 SAGE Publications General Medicine http://dx.doi.org/10.2217/17455057.3.4.409 <jats:p> The problems that arise in connection with the menopause have been treated for many years with various hormone-replacement therapy formulations. The spironolactone derivative drospirenone is a novel progestin that, in combination with estradiol, provides a new low-dose, continuous, combined hormone therapy with a broad and safe activity profile. Through its antiandrogenic and antimineralocorticoid properties, drospirenone acts specifically against menopausal symptoms, provides protection of the endometrium, does not counteract the effect of estradiol on bone metabolism and has a beneficial effect on body weight and lipid metabolism. Its effect on blood pressure is particularly relevant: drospirenone blocks the aldosterone receptor and thus has a regulating effect on the renin–angiotensin–aldosterone system and so promotes enhanced sodium/water excretion. </jats:p> Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women Women's Health |
| doi_str_mv |
10.2217/17455057.3.4.409 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjIxNy8xNzQ1NTA1Ny4zLjQuNDA5 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjIxNy8xNzQ1NTA1Ny4zLjQuNDA5 |
| institution |
DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 |
| imprint |
SAGE Publications, 2007 |
| imprint_str_mv |
SAGE Publications, 2007 |
| issn |
1745-5065 |
| issn_str_mv |
1745-5065 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
huber2007combinationofdrospirenoneandestradiolanewhormonetherapyinpostmenopausalwomen |
| publishDateSort |
2007 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Women's Health |
| source_id |
49 |
| title |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_unstemmed |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_full |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_fullStr |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_full_unstemmed |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_short |
Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_sort |
combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women |
| topic |
General Medicine |
| url |
http://dx.doi.org/10.2217/17455057.3.4.409 |
| publishDate |
2007 |
| physical |
409-415 |
| description |
<jats:p> The problems that arise in connection with the menopause have been treated for many years with various hormone-replacement therapy formulations. The spironolactone derivative drospirenone is a novel progestin that, in combination with estradiol, provides a new low-dose, continuous, combined hormone therapy with a broad and safe activity profile. Through its antiandrogenic and antimineralocorticoid properties, drospirenone acts specifically against menopausal symptoms, provides protection of the endometrium, does not counteract the effect of estradiol on bone metabolism and has a beneficial effect on body weight and lipid metabolism. Its effect on blood pressure is particularly relevant: drospirenone blocks the aldosterone receptor and thus has a regulating effect on the renin–angiotensin–aldosterone system and so promotes enhanced sodium/water excretion. </jats:p> |
| container_issue |
4 |
| container_start_page |
409 |
| container_title |
Women's Health |
| container_volume |
3 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792322412379897861 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:17:20.011Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Combination+of+Drospirenone+and+Estradiol%3A+A+New+Hormone+Therapy+in+Postmenopausal+Women&rft.date=2007-07-01&genre=article&issn=1745-5065&volume=3&issue=4&spage=409&epage=415&pages=409-415&jtitle=Women%27s+Health&atitle=Combination+of+Drospirenone+and+Estradiol%3A+A+New+Hormone+Therapy+in+Postmenopausal+Women&aulast=Huber&aufirst=Johannes+C&rft_id=info%3Adoi%2F10.2217%2F17455057.3.4.409&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792322412379897861 |
| author | Huber, Johannes C |
| author_facet | Huber, Johannes C, Huber, Johannes C |
| author_sort | huber, johannes c |
| container_issue | 4 |
| container_start_page | 409 |
| container_title | Women's Health |
| container_volume | 3 |
| description | <jats:p> The problems that arise in connection with the menopause have been treated for many years with various hormone-replacement therapy formulations. The spironolactone derivative drospirenone is a novel progestin that, in combination with estradiol, provides a new low-dose, continuous, combined hormone therapy with a broad and safe activity profile. Through its antiandrogenic and antimineralocorticoid properties, drospirenone acts specifically against menopausal symptoms, provides protection of the endometrium, does not counteract the effect of estradiol on bone metabolism and has a beneficial effect on body weight and lipid metabolism. Its effect on blood pressure is particularly relevant: drospirenone blocks the aldosterone receptor and thus has a regulating effect on the renin–angiotensin–aldosterone system and so promotes enhanced sodium/water excretion. </jats:p> |
| doi_str_mv | 10.2217/17455057.3.4.409 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjIxNy8xNzQ1NTA1Ny4zLjQuNDA5 |
| imprint | SAGE Publications, 2007 |
| imprint_str_mv | SAGE Publications, 2007 |
| institution | DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4 |
| issn | 1745-5065 |
| issn_str_mv | 1745-5065 |
| language | English |
| last_indexed | 2024-03-01T11:17:20.011Z |
| match_str | huber2007combinationofdrospirenoneandestradiolanewhormonetherapyinpostmenopausalwomen |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 409-415 |
| publishDate | 2007 |
| publishDateSort | 2007 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Women's Health |
| source_id | 49 |
| spelling | Huber, Johannes C 1745-5065 1745-5065 SAGE Publications General Medicine http://dx.doi.org/10.2217/17455057.3.4.409 <jats:p> The problems that arise in connection with the menopause have been treated for many years with various hormone-replacement therapy formulations. The spironolactone derivative drospirenone is a novel progestin that, in combination with estradiol, provides a new low-dose, continuous, combined hormone therapy with a broad and safe activity profile. Through its antiandrogenic and antimineralocorticoid properties, drospirenone acts specifically against menopausal symptoms, provides protection of the endometrium, does not counteract the effect of estradiol on bone metabolism and has a beneficial effect on body weight and lipid metabolism. Its effect on blood pressure is particularly relevant: drospirenone blocks the aldosterone receptor and thus has a regulating effect on the renin–angiotensin–aldosterone system and so promotes enhanced sodium/water excretion. </jats:p> Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women Women's Health |
| spellingShingle | Huber, Johannes C, Women's Health, Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women, General Medicine |
| title | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_full | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_fullStr | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_full_unstemmed | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_short | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| title_sort | combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women |
| title_unstemmed | Combination of Drospirenone and Estradiol: A New Hormone Therapy in Postmenopausal Women |
| topic | General Medicine |
| url | http://dx.doi.org/10.2217/17455057.3.4.409 |